is it safe to switch from semaglutide to tirzepatide Tirzepatide? Switching from Semaglutide to Tirzepatide:

Even with the possible blood vessel growth, it was shown to suppress 70% of genes overexpressed in metastatic colon cancer in the lab

[5] PeutzJeghers syndrome causes pigmentation of the skin and mucous surfaces with melanin, and polyps in the digestive tract

2024;403(10434):e21-31

In clinical trials of FDA-approved medications used alongside diet and exercise: Participants taking Wegovy (semaglutide 2.4 mg) lost an average of about 15% of body weight over 68 weeks. Participants taking Zepbound (tirzepatide 15 mg) lost an average of about 20% of body weight over 72 weeks. These are average results observed under clinical trial conditions